Filter
161
Text search:
Prévalence
du
VIH
Featured
Recommendations
10
New Publications
34
Language
Document type
No document type
95
Studies & Reports
30
Guidelines
17
Fact sheets
7
Strategic & Response Plan
4
Manuals
3
Training Material
2
Infographics
2
Resource Platforms
1
Countries / Regions
Senegal
15
Benin
13
South Africa
12
Burkina Faso
6
Central African Republic
5
Congo, Democratic Republic of
4
Cameroon
4
Haiti
4
Africa
4
Rwanda
3
Myanmar / Burma
3
Global
3
Zimbabwe
2
Lesotho
2
South–East Asia Region
2
Latin America and the Carribbean
2
Russia
2
Nigeria
1
Guinea-Bissau
1
Ethiopia
1
Somalia
1
Nepal
1
Kenya
1
Tanzania
1
Cambodia
1
Mozambique
1
Brazil
1
North Macedonia
1
Ecuador
1
Angola
1
Madagascar
1
Western Pacific Region
1
Western and Central Europe
1
Eastern Europe
1
Armenia
1
Georgia
1
Jamaica
1
Belgium
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
84
Clinical Guidelines
15
Women & Child Health
7
Public Health
2
Pharmacy & Technologies
2
Capacity Building
1
Key Resources
1
Toolboxes
HIV
27
TB
26
Mental Health
9
COVID-19
7
Polio
3
Disability
2
Pharmacy
2
Ebola
1
Cholera
1
Refugee
1
AMR
1
Caregiver
1
NTDs
1
Health Financing Toolbox
1
NCDs
1
Policy Brief. More languages available here https://apps.who.int/iris/handle/10665/179517
An introduction to 90-90-90 in South Africa
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Previous studies have highlighted a range of individual determinants associated with HIV testing but few have assessed the role of contextual factors. The objective of this paper is to examine the influence of both individual and community-level determinants of HIV testing uptake in Burkina Faso.
Sur la base des informations disponibles au 28 février 2021
Rapid Policy Brief Series Series 14: COVID-19 and hypertension
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
Afr J Tradit Complement Altern Med. (2016) 13(4):123-131
Out of 400 questionnaires distributed to the participants, 389 were returned with data acceptable for analysis. Ages of the participants ranged from 18 to 75 years (Mean=43 + 11.6). Out of the 272 (69.9%) participants who conceded that th ...
Out of 400 questionnaires distributed to the participants, 389 were returned with data acceptable for analysis. Ages of the participants ranged from 18 to 75 years (Mean=43 + 11.6). Out of the 272 (69.9%) participants who conceded that th ...
Journal of Infection and Public Health 12 (2019) 213–223
Техническая записка;
Целью настоящей Технической записки является оказание содействия кандидатам наполучение грантов Глобального фонда при рассмотрении
...
